Maternal alloimmunization occurs when a woman makes red blood cell antibodies as a result of foreign blood mixing. These antibodies can cross the placenta and attack the unborn child, a disease called hemolytic disease of the fetus and newborn (HDFN). HDFN can have devastating consequences including anemia, hyperbilirubinemia, and death. With close monitoring and timely treatment, babies with HDFN have a very high survival rate.
The Allo Hope Foundation was founded to educate and support families and providers who are navigating alloimmunization and HDFN.
Are you a patient just learning about your antibodies? Start here for an introduction to what is happening in your body.Start Here
Are you a provider looking for the most current, evidence-based guidelines for the management of alloimmunized pregnancies?Learn More
Journey with our families as they go through pregnancy dealing with alloimmunization and HDFN.
Our mission is to prevent any harm, stillbirth or infant death caused by alloimmunization and HDFN. We are dedicated to providing patient advocacy, support and education while promoting research and improving healthcare practices for the condition.